Back to Journals » Psoriasis: Targets and Therapy » Volume 8

Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date

Total article views   HTML views PDF downloads Totals
11,642 Dovepress* 9,313+ 1,376 10,689
PubMed Central* 2,329 418 2,747
Totals 11,642 1,794 13,436
*Since 29 August 2018

View citations on PubMed Central and Google Scholar